Implementation of Oncotype Dx to Guide Chemotherapy Sparing for Women with Postmenopausal N1-3, ER-positive, HER-2-negative Breast Cancer

Autor: Rajakumar, L., Glendenning, J., Hall, J., Burcombe, R., McCormick, G., Hegarty, G., Harper-Wynne, C., Brown, B., Moss, C., Thomas, C., Jyothirmayi, R., Osman, M., Nikiforidis, L.

Publikováno v: In Clinical Oncology April 2024 36(4):e111-e111

Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence.

Autor: Bellos, Ioannis^1,2 (AUTHOR) bellosg@windowslive.com, Lagiou, Pagona¹ (AUTHOR), Benetou, Vassiliki¹ (AUTHOR), Marinaki, Smaragdi² (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6181. 17p.

Novel Insights into Diabetic Kidney Disease.

Autor: Młynarska, Ewelina¹ (AUTHOR) ewelina.mlynarska@umed.lodz.pl, Buławska, Dominika¹ (AUTHOR), Czarnik, Witold¹ (AUTHOR), Hajdys, Joanna¹ (AUTHOR), Majchrowicz, Gabriela¹ (AUTHOR), Prusinowski, Filip¹ (AUTHOR), Stabrawa, Magdalena¹ (AUTHOR), Rysz, Jacek² (AUTHOR), Franczyk, Beata¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10222. 24p.

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.

Autor: Halden TAS; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Kvitne KE; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway k.e.kvitne@farmasi.uio.no., Midtvedt K; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Rajakumar L; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Robertsen I; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway., Brox J; Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway., Bollerslev J; Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Hartmann A; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Åsberg A; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Section of Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway., Jenssen T; Section of Nephrology, Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Diabetes care [Diabetes Care] 2019 Jun; Vol. 42 (6), pp. 1067-1074. Date of Electronic Publication: 2019 Mar 12.

Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single‐Cell Transcriptomics.

Autor: Zhang, Xin¹ (AUTHOR), Liang, Boxuan² (AUTHOR), Huang, Yuji² (AUTHOR), Meng, Hao² (AUTHOR), Li, Zhiming² (AUTHOR), Du, Jiaxin² (AUTHOR), Zhou, Lang³ (AUTHOR), Zhong, Yizhou² (AUTHOR), Wang, Bo² (AUTHOR), Lin, Xi² (AUTHOR), Yu, Guangchuang³ (AUTHOR), Chen, Xuewei¹ (AUTHOR), Lu, Weixiang¹ (AUTHOR), Chen, Zhe‐Sheng⁴ (AUTHOR), Yang, Xingfen² (AUTHOR), Huang, Zhenlie² (AUTHOR) huangzhenlie858252@smu.edu.cn

Publikováno v: Advanced Science. 12/27/2023, Vol. 10 Issue 36, p1-16. 16p.